The Journal of Toxicological Sciences
Online ISSN : 1880-3989
Print ISSN : 0388-1350
ISSN-L : 0388-1350
Original Article
Variation and classification of chemically-induced zebrafish malformations for the ICH S5 (R3) guideline: an atlas for zebrafish teratogenesis
Kanako Mori, Yoshinobu Aoki, Mai Hayashi, Wataru Sugimoto, Mizuho Ono, Saaya Umekita, Tatsuhiro Niino, Tomonori Ebata, Fumito Mikashima, Kazushige Maki, Toshio Tanaka, Hiromi Hirata, Hajime Kojima
Author information
  • Kanako Mori

    Non-Clinical Biomedical Science, Applied Research & Operations, Astellas Pharma Inc.

  • Yoshinobu Aoki

    Ideation & Creation Group, Discovery Accelerator, Astellas Pharma Inc.

  • Mai Hayashi

    Drug Development Laboratories, Maruho Co., Ltd.

  • Wataru Sugimoto

    Drug Development Laboratories, Maruho Co., Ltd.

  • Mizuho Ono

    Product Stewardship Promotion Department, Mitsubishi Chemical Research Corporation

  • Saaya Umekita

    Product Stewardship Promotion Department, Mitsubishi Chemical Research Corporation

  • Tatsuhiro Niino

    Product Stewardship Promotion Department, Mitsubishi Chemical Research Corporation

  • Tomonori Ebata

    Research Department, Gotemba Laboratory, BoZo Research Center Inc.

  • Fumito Mikashima

    Pharmaceuticals and Medical Devices Agency (PMDA)

  • Kazushige Maki

    Pharmaceuticals and Medical Devices Agency (PMDA)

  • Toshio Tanaka

    Department of Systems Pharmacology, Mie University Graduate School of Medicine

  • Hiromi Hirata

    Department of Chemistry and Biological Science, College of Science and Engineering, Aoyama Gakuin University

  • Hajime Kojima

    National Institute of Health Science
    Department of Pharmaceutical Engineering, Faculty of Engineering, Sanyo-Onoda City University

Corresponding author

ORCID
Keywords: Alternative method, ICH S5(R3), Pharmaceuticals, Teratogenicity, Malformations and embryo-fetal lethality (MEFL), Zebrafish
JOURNAL FREE ACCESS FULL-TEXT HTML
Supplementary material

2025 Volume 50 Issue 8 Pages 431-444

Details
  • Published: 2025 Received: January 24, 2025 Released on J-STAGE: August 01, 2025 Accepted: June 10, 2025 Advance online publication: - Revised: -
Full-text HTML Download PDF (4319K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

How to download citation
Contact us
Abstract

Exposure of embryos or fetuses to harmful substances, such as teratogens, can result in embryonic or fetal death and a wide range of malformations. Zebrafish models have emerged as a valuable tool for assessing developmental toxicity and safety profiles of chemical compounds. Our previous research demonstrated that zebrafish larvae exhibit developmental abnormalities that mirror those observed in mammalian studies for more than 80% of the known Reference Compounds listed in the ICH S5 (R3) guideline. In this study, we presented high-resolution images depicting pharmaceutical-induced malformations across multiple anatomical regions, including the body axis, somites, notochord, fins, head, eyes, otoliths, jaw, heart, abdomen, and whole body. Frequent co-occurrence of specific defects, such as body axis and notochord malformations, was observed as described previously. Some physiological and morphological features, including heartbeat rate alterations and swim bladder inflation, were deemed dispensable for MEFL testing in zebrafish. Reproducibility was confirmed through inter-laboratory testing conducted both within our group and by other groups, supporting the reliability of zebrafish MEFL testing as an alternative approach in line with ICH S5 (R3).

References (30)
Related articles (0)
Figures (6)
Content from these authors
Supplementary material (1)
Result List ()
Cited by (1)
© 2025 The Japanese Society of Toxicology
Previous article
Favorites & Alerts

Recently viewed articles
Share this page
Top

Register with J-STAGE for free!

Register

Already have an account? Sign in here

AltStyle によって変換されたページ (->オリジナル) /